P

Pharmena SA
WSE:PHR

Watchlist Manager
Pharmena SA
WSE:PHR
Watchlist
Price: 3.82 PLN -6.37% Market Closed
Market Cap: 42.6m PLN

Wall Street
Price Targets

PHR Price Targets Summary
Pharmena SA

There are no price targets for PHR.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Pharmena SA Competitors:
Price Targets
4927
Pola Orbis Holdings Inc
3% Upside
EMAMILTD
Emami Ltd
33% Upside
4933
I Ne Co Ltd
72% Upside
4452
Kao Corp
25% Upside
300146
By-health Co Ltd
13% Upside
IPAR
Inter Parfums Inc
40% Upside

Revenue
Forecast

Revenue Estimate
Pharmena SA

For the last 13 years the compound annual growth rate for Pharmena SA's revenue is -24%. The projected CAGR for the next 8 years is 77%.

-24%
Past Growth
77%
Estimated Growth
Estimates Accuracy
-8%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Pharmena SA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-20%
Average Miss

Net Income
Forecast

Net Income Estimate
Pharmena SA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
47%
Average Beat
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is PHR's stock price target?
Not Available

PHR doesn't have any price targets made by Wall Street professionals.

What is Pharmena SA's Revenue forecast?
Projected CAGR
77%

For the last 13 years the compound annual growth rate for Pharmena SA's revenue is -24%. The projected CAGR for the next 8 years is 77%.

Back to Top